Drug Atlas

NDC 50474-783 – Bimzelx

Bimekizumab 320 mg/2mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC50474-783

Product details

Brand name: Bimzelx
Generic name: Bimekizumab
Labeler: UCB, Inc.
Dosage form: Injection, Solution
Route: Subcutaneous
Marketing category: BLA · BLA761151
Marketed since: December 5, 2024
Listing expires: December 31, 2026

Active ingredients

Bimekizumab 320 mg/2mL

Uses, dosage, side effects and warnings for Bimzelx →

Package NDC codes (1)

Package NDC	Description	Since
50474-783-78	1 SYRINGE, GLASS in 1 CARTON (50474-783-78) / 2 mL in 1 SYRINGE, GLASS	Dec 5, 2024

Other Bimzelx products

50474-780 Bimekizumab 160 mg/mL · Injection, Solution · UCB, Inc.
50474-781 Bimekizumab 160 mg/mL · Injection, Solution · UCB, Inc.
50474-782 Bimekizumab 320 mg/2mL · Injection, Solution · UCB, Inc.